สายพันธุ์ของ SARS-CoV-2 (Thai Wikipedia)

Analysis of information sources in references of the Wikipedia article "สายพันธุ์ของ SARS-CoV-2" in Thai language version.

refsWebsite

Global rank Thai rank

60nih.gov

4^th place

7^th place

55doi.org

2^nd place

4^th place

18web.archive.org

1^st place

16who.int

195^th place

174^th place

13cov-lineages.org

low place

12semanticscholar.org

11^th place

61^st place

12publishing.service.gov.uk

1,877^th place

2,344^th place

9gov.uk

432^nd place

1,484^th place

9worldcat.org

5^th place

17^th place

9nytimes.com

7^th place

41^st place

8reuters.com

49^th place

87^th place

7medrxiv.org

low place

7sciencemag.org

857^th place

309^th place

6bbc.com

20^th place

23^rd place

6cdc.gov

218^th place

283^rd place

6europa.eu

68^th place

166^th place

6harvard.edu

18^th place

43^rd place

4news-medical.net

8,069^th place

6,608^th place

4virological.org

low place

4gisaid.org

low place

4outbreak.info

low place

4thehindu.com

52^nd place

534^th place

3bbc.co.uk

8^th place

15^th place

3washingtonpost.com

34^th place

131^st place

3abs-cbn.com

528^th place

748^th place

3cnnphilippines.com

2,993^rd place

5,157^th place

3biorxiv.org

5,061^st place

1,509^th place

3moh.gov.my

low place

3ssi.dk

low place

2oup.com

485^th place

723^rd place

2bmj.com

1,226^th place

533^rd place

2thelancet.com

2,393^rd place

7,254^th place

2telegraph.co.uk

30^th place

94^th place

2github.com

383^rd place

2,367^th place

2statnews.com

8,771^st place

low place

2khub.net

low place

2cogconsortium.uk

low place

2torontosun.com

1,440^th place

low place

2aljazeera.com

268^th place

353^rd place

2sciencemediacentre.org

low place

2indiatoday.in

94^th place

2,087^th place

2nextstrain.org

low place

1mdpi.com

2,912^th place

low place

1nsw.gov.au

640^th place

2,719^th place

1cnn.com

28^th place

75^th place

1covariants.org

low place

1ctvnews.ca

768^th place

2,461^st place

1sciencespeaksblog.org

low place

1nccid.ca

low place

1youtube.com

9^th place

1cmmid.github.io

low place

1sacoronavirus.co.za

low place

1scribd.com

482^nd place

1,097^th place

1japantoday.com

3,795^th place

2,312^th place

1researchsquare.com

low place

1uol.com.br

74^th place

1,511^th place

1globalnews.ca

985^th place

6,766^th place

1theconversation.com

928^th place

2,120^th place

1cedars-sinai.org

low place

1newswise.com

9,751^st place

low place

1rivm.nl

low place

1businessinsider.com

140^th place

281^st place

1aftenposten.no

1,779^th place

7,054^th place

1irishtimes.com

266^th place

1,188^th place

1thestar.com.my

574^th place

362^nd place

1newscientist.com

774^th place

756^th place

1abc.net.au

139^th place

332^nd place

1dw.com

204^th place

590^th place

1lrt.lt

5,044^th place

low place

1theguardian.com

12^th place

51^st place

1timesofindia.com

242^nd place

4,364^th place

1uni-graz.at

8,173^rd place

low place

1innophore.com

low place

1biontech.de

low place

1i-base.info

low place

1niid.go.jp

low place

1livescience.com

1,190^th place

1,616^th place

1npr.org

92^nd place

603^rd place

1osu.edu

2,333^rd place

1,989^th place

1creativecommons.org

1,010^th place

1,155^th place

1medicalxpress.com

8,255^th place

low place

1straitstimes.com

543^rd place

415^th place

1gmanetwork.com

824^th place

1,736^th place

1focusmalaysia.my

low place

1scientificamerican.com

896^th place

1,011^th place

1fda.gov

447^th place

693^rd place

1ssrn.com

703^rd place

1,124^th place

1ft.com

210^th place

349^th place

1pfizer.com

low place

1jnj.com

low place

1clinicaltrials.gov

5,225^th place

7,482^nd place

abc.net.au

"Queensland travellers have hotel quarantine extended after Russian variant of coronavirus detected". www.abc.net.au (ภาษาอังกฤษแบบออสเตรเลีย). 2021-03-03. สืบค้นเมื่อ 2021-03-03.

abs-cbn.com

news.abs-cbn.com

"DOH confirms detection of 2 SARS-CoV-2 mutations in Region 7". ABS-CBN News (ภาษาอังกฤษ). 2021-02-18. สืบค้นเมื่อ 2021-03-13.
"DOH confirms new COVID-19 variant first detected in PH, first case of Brazil variant". ABS-CBN News (ภาษาอังกฤษ). 2021-03-13. สืบค้นเมื่อ 2021-03-13.
"UK reports 2 cases of COVID-19 variant first detected in Philippines". ABS-CBN. 2021-03-17. สืบค้นเมื่อ 2021-03-21.

aftenposten.no

"En ny variant av koronaviruset er oppdaget i Norge. Hva vet vi om den?" [A new variant of the coronavirus has been discovered in Norway. What do we know about it?] (ภาษานอร์เวย์). Aftenposten. 2021-02-18. สืบค้นเมื่อ 2021-02-18.

aljazeera.com

bbc.co.uk

"Covid: Is there a limit to how much worse variants can get?". BBC. 2021-06-12.
"Covid: Ireland, Italy, Belgium and Netherlands ban flights from UK". BBC News. 2020-12-20.
Schraer, R (2020-07-18). "Coronavirus: Are mutations making it more infectious?". BBC News. สืบค้นเมื่อ 2021-01-03.

bbc.com

"Coronavirus variants and mutations: The science explained". BBC News (ภาษาอังกฤษแบบบริติช). 2021-01-06. สืบค้นเมื่อ 2021-02-02.
Gallagher, J (2021-01-22). "Coronavirus: UK variant 'may be more deadly'". BBC News. สืบค้นเมื่อ 2021-01-22.
Schraer, Rachel (2021-06-04). "'Nepal variant': What's the mutation stopping green list trips to Portugal?". BBC News. สืบค้นเมื่อ 2021-06-18.
Biswas, Soutik (2021-06-23). "Delta plus: Scientists say too early to tell risk of Covid-19 variant". BBC News. สืบค้นเมื่อ 2021-06-23.
Roberts, M (2021-02-16). "Another new coronavirus variant seen in the UK". BBC News. สืบค้นเมื่อ 2021-02-16.
"Covid: South Africa halts AstraZeneca vaccine rollout over new variant". BBC News Online. 2021-02-08. สืบค้นเมื่อ 2021-02-08.

biontech.de

"BioNTech: We aspire to individualize cancer medicine". BioNTech (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-02-22.

biorxiv.org

Tandel, Dixit; Gupta, Divya; Sah, Vishal; Harshan, Krishnan Harinivas (2021-04-30). "N440K variant of SARS-CoV-2 has Higher Infectious Fitness". bioRxiv (ภาษาอังกฤษ): 2021.04.30.441434. doi:10.1101/2021.04.30.441434.
Schroers, B; Gudimella, R; Bukur, T; Roesler, T; Loewer, M; Sahin, U (2021-02-04). "Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates". bioRxiv (ภาษาอังกฤษ). doi:10.1101/2021.02.04.429765. S2CID 231885609.
Tu, H; Avenarius, MR; Kubatko, L; Hunt, M; Pan, X; Ru, P; และคณะ (2021-01-26). "Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio". bioRxiv (ภาษาอังกฤษ): 2021.01.12.426407. doi:10.1101/2021.01.12.426407. S2CID 231666860.

bmj.com

Nyberg, T; Twohig, KA; Harris, RJ; Seaman, SR; Flannagan, J; Allen, H; และคณะ (2021-06-15). "Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis". BMJ. 373: n1412. doi:10.1136/bmj.n1412. ISSN 1756-1833. PMID 34130987. S2CID 235187479.
"Covid-19 and evolutionary pressure - can we predict which genetic dangers lurk beyond the horizon?". 2021-06-14: n230. {{cite journal}}: Cite journal ต้องการ |journal= (help)

businessinsider.com

"A coronavirus variant with a mutation that 'likely helps it escape' antibodies is already in at least 11 countries, including the US". Business Insider. 2021-02-16. สืบค้นเมื่อ 2021-02-16.

cdc.gov

"SARS-CoV-2 Variant Classifications and Definitions". CDC.gov. Centers for Disease Control and Prevention. 2020-02-11.
"Emerging SARS-CoV-2 Variants". CDC.gov (Science brief). Centers for Disease Control and Prevention. 2021-01-28. สืบค้นเมื่อ 2021-01-04. บทความนี้รวมเอาเนื้อความจากแหล่งอ้างอิงนี้ ซึ่งเป็นสาธารณสมบัติ
"SARS-CoV-2 Variant Classifications and Definitions". CDC.gov. Centers for Disease Control and Prevention. 2021-05-12. สืบค้นเมื่อ 2021-05-16.
"Emerging SARS-CoV-2 Variants". cdc.org (Science brief). Centers for Disease Control and Prevention. 2021-01-28. สืบค้นเมื่อ 2021-01-04. บทความนี้รวมเอาเนื้อความจากแหล่งอ้างอิงนี้ ซึ่งเป็นสาธารณสมบัติ
"SARS-CoV-2 Variant Classifications and Definitions". Centers for Disease Control and Prevention. U.S. Department of Health & Human Services. 2021-03-24. สืบค้นเมื่อ 2021-04-04.
"SARS-CoV-2 Variant Classifications and Definitions". CDC.gov. Centers for Disease Control and Prevention. 2021-05-12. สืบค้นเมื่อ 2021-05-16.

cedars-sinai.org

"Southern California COVID-19 Strain Rapidly Expands Global Reach". Cedars-Sinai Newsroom. Los Angeles. 2021-02-11. สืบค้นเมื่อ 2021-03-17.

clinicaltrials.gov

"A Phase 2A/B, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1 Adjuvant in South African Adult Subjects Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV". ClinicalTrials.gov. United States National Library of Medicine. 2020-10-30.

cmmid.github.io

"Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England". CMMID Repository. 2020-12-23. สืบค้นเมื่อ 2021-01-24 – โดยทาง GitHub.
- Cited in "Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update" (PDF). Stockholm: European Centre for Disease Prevention and Control (ECDC). 2021-01-21. p. 9. สืบค้นเมื่อ 2021-01-24.

cnn.com

edition.cnn.com

Azad, Arman (2021-03-17). "Coronavirus strains first detected in California are officially 'variants of concern,' CDC says". CNN. สืบค้นเมื่อ 2021-06-06.

cnnphilippines.com

Santos, E (2021-03-13). "DOH reports COVID-19 variant 'unique' to PH, first case of Brazil variant". CNN Philippines. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-03-16. สืบค้นเมื่อ 2021-03-17.
"PH discovered new COVID-19 variant earlier than Japan, expert clarifies". CNN Philippines. 2021-03-13. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-03-17. สืบค้นเมื่อ 2021-03-17.
"Japan detects new coronavirus variant from traveler coming from PH". CNN Philippines. 2021-03-13. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-03-17. สืบค้นเมื่อ 2021-03-21.

cogconsortium.uk

"COG-UK Report on SARS-CoV-2 Spike mutations of interest in the UK" (PDF). Covid-19 Genomics UK Consortium. 2021-01-15. สืบค้นเมื่อ 2021-01-25.
COG-UK update on SARS-CoV-2 Spike mutations of special interest: Report 1 (PDF) (Report). COVID-19 Genomics UK Consortium (COG-UK). 2020-12-20. p. 7. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2020-12-25. สืบค้นเมื่อ 2020-12-31.

cov-lineages.org

"Lineage descriptions". cov-lineages.org. Pango team.
"B.1.525 international lineage report". cov-lineages.org. Pango team. สืบค้นเมื่อ 2021-06-04.
"B.1.525". cov-lineages.org. Pango team. สืบค้นเมื่อ 2021-03-22.
"B.1.525". cov-lineages.org. Pango team. สืบค้นเมื่อ 2021-03-22.
"PANGO lineages-Lineage B.1.1.28". cov-lineages.org. สืบค้นเมื่อ 2021-02-04.^{[ไม่อยู่ในแหล่งอ้างอิง]}
"PANGO lineages Lineage B.1.1.7". cov-lineages.org. สืบค้นเมื่อ 2021-05-15.
"P.1 report". cov-lineages.org. สืบค้นเมื่อ 2021-02-08.{{cite web}}: CS1 maint: url-status (ลิงก์)
"PANGO lineages". cov-lineages.org. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-06-03. สืบค้นเมื่อ 2021-04-18.
"B.1.429". Rambaut Group, University of Edinburgh. PANGO Lineages. 2021-02-15. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-28. สืบค้นเมื่อ 2021-02-16.
"PANGO lineages Lineage P.2". COV lineages. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-28. สืบค้นเมื่อ 2021-01-28. P.2… Alias of B.1.1.28.2, Brazilian lineage
"Lineage B.1.1.207". cov-lineages.org. Pango team. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-01-27. สืบค้นเมื่อ 2021-03-11.
"PANGO lineages Lineage B.1.618". cov-lineages. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-05-14. สืบค้นเมื่อ 2021-04-23.
"PANGO lineages". cov-lineages.org. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-06-03. สืบค้นเมื่อ 2021-04-18.

covariants.org

"Variant: 20J/501Y.V3". covariants.org. 2021-04-01. สืบค้นเมื่อ 2021-04-06.

creativecommons.org

Maison, DP; Ching, LL; Shikuma, CM; Nerurkar, VR (January 2021). "Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation". bioRxiv: 2021.01.06.425497. doi:10.1101/2021.01.06.425497. PMC 7805472. PMID 33442699. Available under CC BY 4.0.

ctvnews.ca

Flanagan, R (2021-02-02). "Why the WHO won't call it the 'U.K. variant', and you shouldn't either". Coronavirus (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-02-12.

doi.org

Shahhosseini, Nariman; Babuadze, George; Wong, Gary; Kobinger, Gary (2021). "Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern". Microorganisms. 9 (5): 926. doi:10.3390/microorganisms9050926. PMID 33925854. S2CID 233460887. สืบค้นเมื่อ 2021-05-04.
Kupferschmidt, K (2021-01-15). "New coronavirus variants could cause more reinfections, require updated vaccines". Science. American Association for the Advancement of Science. doi:10.1126/science.abg6028. สืบค้นเมื่อ 2021-02-02.
Shahhosseini, Nariman; Wong, Gary; Kobinger, Gary; Chinikar, Sadegh (2021). "SARS-CoV-2 spillover transmission due to recombination event". Gene Reports. 23: 101045. doi:10.1016/j.genrep.2021.101045. PMC 7884226. PMID 33615041.
Yurkovetskiy, Leonid; Wang, Xue; Pascal, Kristen E.; Tomkins-Tinch, Christopher; Nyalile, Thomas P.; Wang, Yetao; และคณะ (October 2020). "Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant". Cell. 183 (3): 739-751.e8. doi:10.1016/j.cell.2020.09.032. PMC 7492024. PMID 32991842.
Thomson, Emma C.; Rosen, Laura E.; Shepherd, James G.; Spreafico, Roberto; da Silva Filipe, Ana; Wojcechowskyj, Jason A.; และคณะ (March 2021). "Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity". Cell. 184 (5): 1171-1187.e20. doi:10.1016/j.cell.2021.01.037. PMC 7843029. PMID 33621484.
Davies, NG; Abbott, S; Barnard, RC; Jarvis, CI; Kucharski, AJ; Munday, JD; และคณะ (2021). "Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England". Science. 372 (6538): eabg3055. doi:10.1126/science.abg3055. PMC 8128288. PMID 33658326.{{cite journal}}: CS1 maint: multiple names: authors list (ลิงก์)
Nyberg, T; Twohig, KA; Harris, RJ; Seaman, SR; Flannagan, J; Allen, H; และคณะ (2021-06-15). "Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis". BMJ. 373: n1412. doi:10.1136/bmj.n1412. ISSN 1756-1833. PMID 34130987. S2CID 235187479.
Zhao, S; Lou, J; Cao, L; Zheng, H; Chong, MK; Chen, Z; และคณะ (2021-01-28). "Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis". Journal of Travel Medicine. 28 (2). doi:10.1093/jtm/taab011. ISSN 1195-1982. PMC 7928809. PMID 33506254.
Coutinho, RM; Marquitti, FM; Ferreira, LS; Borges, ME; da Silva, RL; Canton, O; และคณะ (2021-03-23). "Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant". medRxiv (Preprint): 9. doi:10.1101/2021.03.03.21252706. S2CID 232119656. สืบค้นเมื่อ 2021-04-29. The new variant was found to be about 2.6 times more transmissible (95% Confidence Interval (CI): 2.4-2.8) than previous circulating variant (s). ... Table 1: Summary of the fitted parameters and respective confidence intervals considering the entire period, November 1, 2020-January 31, 2021 maintaining the same pathogenicity of the previous variant. Parameter: Relative transmission rate for the new variant. Estimate: 2.61. 2.5%: 2.45. 97.5%: 2.76.
Faria, NR; Mellan, TA; Whittaker, C; Claro, IM; Candido, DS; Mishra, S; และคณะ (2021-05-21). "Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil". Science. 372 (6544): 815–821. doi:10.1126/science.abh2644. ISSN 0036-8075. PMID 33853970. Within this plausible region of parameter space, P.1 can be between 1.7 and 2.4 times more transmissible (50% BCI, 2.0 median, with a 99% posterior probability of being >1) than local non-P1 lineages and can evade 21 to 46% (50% BCI, 32% median, with a 95% posterior probability of being able to evade at least 10%) of protective immunity elicited by previous infection with non-P.1 lineages, corresponding to 54 to 79% (50% BCI, 68% median) cross-immunity ... We estimate that infections are 1.2 to 1.9 times more likely (50% BCI, median 1.5, 90% posterior probability of being >1) to result in mortality in the period after the emergence of P.1, compared with before, although posterior estimates of this relative risk are also correlated with inferred cross-immunity. More broadly, the recent epidemic in Manaus has strained the city’s health care system, leading to inadequate access to medical care. We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus health care system, or both. Detailed clinical investigations of P.1 infections are needed.
Freitas, AR; Lemos, DR; Beckedorff, OA; Cavalcanti, LP; Siqueira, AM; Mello, RC; และคณะ (2021-04-19). "The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions" (Preprint). doi:10.1101/2021.04.13.21255281 – โดยทาง medRxiv. Female 20 to 39 years old, with no pre-existing risk conditions, were at risk of death 5.65 times higher in February (95% CI, 2.9-11.03; p <0.0001) and in the age group of 40 and 59 years old, this risk was 7.7 times higher (95% CI, 5.01-11.83; p <0.0001) comparing with November-December. ... The heterogeneity observed between the age groups was greater when we analyzed the subgroup of the population without preexisting risk conditions where we found that the CFR in the female sex in the second wave was 1.95 times (95% CI, 1.38-2.76) the CFR of the first wave in the population over 85 years old and was 7.7 times (95% CI, 5.01-11.83; p < 0.0001) in the population between 40 and 59 years old. In the male population without previous diseases, the CFR in the second wave was 2.18 (95% CI, 1.62-2.93) times the CFR of the first wave in the population over 85 years old and 5.9 (95% CI, 3.2-10.85; p < 0, 0001) higher in the range between 20 and 39 years old. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Collier, DA; De Marco, A; Gupta, RK; al, et (2021-05-06). "Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies". Nature (Published). 593 (7857): 136–141. doi:10.1038/s41586-021-03412-7. PMID 33706364. We therefore generated pseudoviruses that carried the B.1.1.7 spike mutations with or without the additional E484K substitution and tested these against sera obtained after the first and second dose of the BNT162b2 mRNA vaccine as well as against convalescent sera. After the second vaccine dose, we observed a considerable loss of neutralizing activity for the pseudovirus with the B.1.1.7 spike mutations and E484K (Fig. 3d, e). The mean fold change for the E484K-containing B.1.1.7 spike variant was 6.7 compared with 1.9 for the B.1.1.7 variant, relative to the wild-type spike protein (Fig. 3a-c and Extended Data Fig. 5). Similarly, when we tested a panel of convalescent sera with a range of neutralization titres (Fig. 1f, g and Extended Data Fig. 5), we observed additional loss of activity against the mutant B.1.1.7 spike with E484K, with fold change of 11.4 relative to the wild-type spike protein (Fig. 3f, g and Extended Data Fig. 5).
Deng, X; Garcia-Knight, MA; Khalid, MM; Servellita, V; Wang, C; Morris, MK; และคณะ (2021-03-09). "Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation" (Preprint). doi:10.1101/2021.03.07.21252647. PMC 7987058. PMID 33758899 – โดยทาง medRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Wadman, M (2021-02-23). "California coronavirus strain may be more infectious - and lethal". Science News. doi:10.1126/science.abh2101. สืบค้นเมื่อ 2021-03-17.
Ito, K; Piantham, C; Nishiura, H (2021-06-15). "Predicted domination of variant Delta of SARS-CoV-2 before Tokyo Olympic games, Japan". medRxiv (Preprint). doi:10.1101/2021.06.12.21258835. S2CID 235437370.
Sheikh, A; McMenamin, J; Taylor, B; Robertson, C (2021-06-14). "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness". The Lancet. doi:10.1016/S0140-6736(21)01358-1. ISSN 0140-6736. PMID 34139198.
Yadav, PD; Sapkal, GN; Abraham, P; Ella, R; Deshpande, G; Patil, DY; และคณะ (2021-05-07). "Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees". Clinical Infectious Diseases. Oxford University Press (ciab411). bioRxiv 10.1101/2021.04.23.441101. doi:10.1093/cid/ciab411. PMID 33961693.
Planas, D; Veyer, D; Baidaliuk, A; Staropoli, I; Guivel-Benhassine, F; Rajah, MM; และคณะ (2021-05-27). "Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals". bioRxiv 10.1101/2021.05.26.445838.
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (November 2020). "A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 5 (11): 1403–1407. doi:10.1038/s41564-020-0770-5. PMC 7610519. PMID 32669681. S2CID 220544096. Cited in Alm et al.
Alm, E; Broberg, EK; Connor, T; Hodcroft, EB; Komissarov, AB; Maurer-Stroh, S; และคณะ (August 2020). "Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020". Euro Surveillance. 25 (32). doi:10.2807/1560-7917.ES.2020.25.32.2001410. PMC 7427299. PMID 32794443.
Zhukova, A; Blassel, L; Lemoine, F; Morel, M; Voznica, J; Gascuel, O (November 2020). "Origin, evolution and global spread of SARS-CoV-2". Comptes Rendus Biologies: 1–20. doi:10.5802/crbiol.29. PMID 33274614.
Zhang, W; Davis, B; Chen, SS; Martinez, JS; Plummer, JT; Vail, E (2021). "Emergence of a novel SARS-CoV-2 strain in Southern California, USA". MedRxiv. doi:10.1101/2021.01.18.21249786. S2CID 231646931.
Koyama, T; Platt, D; Parida, L (July 2020). "Variant analysis of SARS-CoV-2 genomes". Bulletin of the World Health Organization. 98 (7): 495–504. doi:10.2471/BLT.20.253591. PMC 7375210. PMID 32742035. We detected in total 65776 variants with 5775 distinct variants.
Hadfield, J; Megill, C; Bell, SM; Huddleston, J; Potter, B; Callender, C; และคณะ (December 2018). Kelso, J (บ.ก.). "Nextstrain: real-time tracking of pathogen evolution". Bioinformatics. 34 (23): 4121–4123. doi:10.1093/bioinformatics/bty407. PMC 6247931. PMID 29790939.
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (March 2021). "Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 6 (3): 415. doi:10.1038/s41564-021-00872-5. PMC 7845574. PMID 33514928.
Wu, Fan; Zhao, Su; Yu, Bin; Chen, Yan-Mei; Wang, Wen; Song, Zhi-Gang; Hu, Yi; Tao, Zhao-Wu; Tian, Jun-Hua; Pei, Yuan-Yuan; Yuan, Ming-Li; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen (2020). "A new coronavirus associated with human respiratory disease in China". Nature. 579 (7798): 265–269. doi:10.1038/s41586-020-2008-3. ISSN 0028-0836.
Chiara, M; Horner, DS; Gissi, C; Pesole, G (May 2021). "Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2". Mol Biol Evol. 38 (6): 2547–2565. doi:10.1093/molbev/msab049. PMC 7928790. PMID 33605421.
Zhou, Peng; Yang, Xing-Lou; Wang, Xian-Guang; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Huang, Chao-Lin; Chen, Hui-Dong; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Liu, Lin-Lin; Yan, Bing; Zhan, Fa-Xian; Wang, Yan-Yi; Xiao, Geng-Fu; Shi, Zheng-Li (2020). "A pneumonia outbreak associated with a new coronavirus of probable bat origin". Nature. 579 (7798): 270–273. doi:10.1038/s41586-020-2012-7. ISSN 0028-0836.
Okada, Pilailuk; Buathong, Rome; Phuygun, Siripaporn; Thanadachakul, Thanutsapa; Parnmen, Sittiporn; Wongboot, Warawan; Waicharoen, Sunthareeya; Wacharapluesadee, Supaporn; Uttayamakul, Sumonmal; Vachiraphan, Apichart; Chittaganpitch, Malinee; Mekha, Nanthawan; Janejai, Noppavan; Iamsirithaworn, Sopon; Lee, Raphael TC; Maurer-Stroh, Sebastian (2020). "Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020". Eurosurveillance. 25 (8). doi:10.2807/1560-7917.ES.2020.25.8.2000097. ISSN 1560-7917.
Chen, RE; Zhang, X; Case, JB; Winkler, ES; Liu, Y; VanBlargan, LA; และคณะ (March 2021). "Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies". Nature Medicine. 27 (4): 717–726. doi:10.1038/s41591-021-01294-w. PMC 8058618. PMID 33664494.
Moustafa, AM; Bianco, C; Denu, L; Ahmed, A; Neide, B; Everett, J; และคณะ (2021-04-21). "Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania". bioRxiv 10.1101/2021.04.21.440801.
Voloch, CM; da Silva Francisco, R; de Almeida, LG; Cardoso, CC; Brustolini, OJ; Gerber, AL; และคณะ (2020). "Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil". doi:10.1101/2020.12.23.20248598. S2CID 229379623 – โดยทาง MedRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Nascimento, V; Souza, V (2021-02-25). "COVID-19 epidemic in the Brazilian state of Amazonas was driven by long-term persistence of endemic SARS-CoV-2 lineages and the recent emergence of the new Variant of Concern P.1". Research Square. doi:10.21203/rs.3.rs-275494/v1. สืบค้นเมื่อ 2021-03-02. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Garcia-Beltran, W; Lam, E; Denis, K (2021-03-12). "Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity". doi:10.1101/2021.02.14.21251704. สืบค้นเมื่อ 2021-04-14 – โดยทาง medrxiv.
Shen, X; Tang, H; Pajon, R; Smith, G; Glenn, GM; Shi, W; และคณะ (April 2021). "Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351". The New England Journal of Medicine. doi:10.1056/NEJMc2103740. PMC 8063884. PMID 33826819.
Larsen, HD; Fonager, J; Lomholt, FK; Dalby, T; Benedetti, G; Kristensen, B; และคณะ (February 2021). "Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020". Euro Surveillance. 26 (5). doi:10.2807/1560-7917.ES.2021.26.5.210009. PMC 7863232. PMID 33541485.
Tandel, Dixit; Gupta, Divya; Sah, Vishal; Harshan, Krishnan Harinivas (2021-04-30). "N440K variant of SARS-CoV-2 has Higher Infectious Fitness". bioRxiv (ภาษาอังกฤษ): 2021.04.30.441434. doi:10.1101/2021.04.30.441434.
Singh, A; Steinkellner, G; Köchl, K; Gruber, K; Gruber, CC (February 2021). "Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2". Scientific Reports. 11 (1): 4320. Bibcode:2021NatSR..11.4320S. doi:10.1038/s41598-021-83761-5. PMC 7900180. PMID 33619331.
Schroers, B; Gudimella, R; Bukur, T; Roesler, T; Loewer, M; Sahin, U (2021-02-04). "Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates". bioRxiv (ภาษาอังกฤษ). doi:10.1101/2021.02.04.429765. S2CID 231885609.
Wise, J (February 2021). "Covid-19: The E484K mutation and the risks it poses". BMJ. 372: n359. doi:10.1136/bmj.n359. PMID 33547053. S2CID 231821685.
Greaney, A (2021-01-04). "Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies". bioRxiv 10.1101/2020.12.31.425021.
Kupferschmidt, K (January 2021). "New mutations raise specter of 'immune escape'". Science. 371 (6527): 329–330. Bibcode:2021Sci...371..329K. doi:10.1126/science.371.6527.329. PMID 33479129.
Tu, H; Avenarius, MR; Kubatko, L; Hunt, M; Pan, X; Ru, P; และคณะ (2021-01-26). "Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio". bioRxiv (ภาษาอังกฤษ): 2021.01.12.426407. doi:10.1101/2021.01.12.426407. S2CID 231666860.
Maison, DP; Ching, LL; Shikuma, CM; Nerurkar, VR (January 2021). "Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation". bioRxiv: 2021.01.06.425497. doi:10.1101/2021.01.06.425497. PMC 7805472. PMID 33442699. Available under CC BY 4.0.
Korber, B; Fischer, WM; Gnanakaran, S; Yoon, H; Theiler, J; Abfalterer, W; และคณะ (August 2020). "Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus". Cell. 182 (4): 812-827.e19. doi:10.1016/j.cell.2020.06.043. PMC 7332439. PMID 32697968.
Hou, YJ; Chiba, S; Halfmann, P; Ehre, C; Kuroda, M; Dinnon, KH; และคณะ (December 2020). "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo". Science. 370 (6523): 1464–1468. Bibcode:2020Sci...370.1464H. doi:10.1126/science.abe8499. PMC 7775736. PMID 33184236. an emergent Asp614→Gly (D614G) substitution in the spike glycoprotein of SARS-CoV-2 strains that is now the most prevalent form globally
Butowt, R; Bilinska, K; Von Bartheld, CS (October 2020). "Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor". ACS Chemical Neuroscience. 11 (20): 3180–3184. doi:10.1021/acschemneuro.0c00596. PMC 7581292. PMID 32997488.
McCarthy, KR; Rennick, LJ; Nambulli, S; Robinson-McCarthy, LR; Bain, WG; Haidar, G; Duprex, WP (March 2021). "Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape". Science. 371 (6534): 1139–1142. Bibcode:2021Sci...371.1139M. doi:10.1126/science.abf6950. PMC 7971772. PMID 33536258.
Burioni, R; Topol, EJ (2021-06-21). "Has SARS-CoV-2 reached peak fitness?". Nature Medicine. doi:10.1038/s41591-021-01421-7. PMID 34155413.
Mahase, E (March 2021). "Covid-19: Where are we on vaccines and variants?". BMJ. 372: n597. doi:10.1136/bmj.n597. PMID 33653708. S2CID 232093175.
Muik, A; Wallisch, AK; Sänger, B; Swanson, KA; Mühl, J; Chen, W; และคณะ (March 2021). "Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera". Science. 371 (6534): 1152–53. Bibcode:2021Sci...371.1152M. doi:10.1126/science.abg6105. PMC 7971771. PMID 33514629.
Wang, P; Nair, MS; Liu, L; Iketani, S; Luo, Y; Guo, Y; และคณะ (March 2021). "Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7". Nature. 593 (7857): 130–35. Bibcode:2021Natur.593..130W. doi:10.1038/s41586-021-03398-2. PMID 33684923.
Mahase, E (February 2021). "Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant". BMJ. 372: n296. doi:10.1136/bmj.n296. PMID 33526412. S2CID 231730012.
Liu, Y; Liu, J; Xia, H; Zhang, X; Fontes-Garfias, CR; Swanson, KA; และคณะ (February 2021). "Neutralizing Activity of BNT162b2-Elicited Serum - Preliminary Report". The New England Journal of Medicine. doi:10.1056/nejmc2102017. PMID 33596352.
Hoffmann, M; Arora, P; Gross, R; Seidel, A; Hoernich, BF; Hahn, AS; และคณะ (March 2021). "1 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies". Cell. 184 (9): 2384-2393.e12. doi:10.1016/j.cell.2021.03.036. PMC 7980144. PMID 33794143.

dw.com

"COVID-19: African variant reveals sequencing lag".

europa.eu

ecdc.europa.eu

"SARS-CoV-2 variants of concern". ECDC.eu. European Centre for Disease Prevention and Control.
Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update (Risk assessment). European Centre for Disease Prevention and Control. 2021-02-02.
"Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England". CMMID Repository. 2020-12-23. สืบค้นเมื่อ 2021-01-24 – โดยทาง GitHub.
- Cited in "Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update" (PDF). Stockholm: European Centre for Disease Prevention and Control (ECDC). 2021-01-21. p. 9. สืบค้นเมื่อ 2021-01-24.
- "SARS-CoV-2 variants of concern as of 6 May 2021". European Centre for Disease Prevention and Control (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-05-12.
- "Detection of new SARS-CoV-2 variants related to mink" (PDF). European Centre for Disease Prevention and Control. 2020-11-12. สืบค้นเมื่อ 2020-11-12.
- "SARS-CoV-2 variants of concern as of 6 May 2021". European Centre for Disease Prevention and Control (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-05-12.

fda.gov

Office of the Commissioner (2021-02-23). "Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants". U.S. Food and Drug Administration (FDA). สืบค้นเมื่อ 2021-03-07.

focusmalaysia.my

"COVID-19 A701V mutation spreads to third wave clusters". focusmalaysia. 2020-12-25.

ft.com

Kuchler, H (2021-01-25). "Moderna develops new vaccine to tackle mutant Covid strain". Financial Times. สืบค้นเมื่อ 2021-01-30.

gisaid.org

"clade tree (from 'Clade and lineage nomenclature')". www.gisaid.org. 2020-07-04. สืบค้นเมื่อ 2021-01-07.
"Global phylogeny, updated by Nextstrain". GISAID. 2021-01-18. สืบค้นเมื่อ 2021-01-19.
"Official hCoV-19 Reference Sequence". GISAID. สืบค้นเมื่อ 2021-05-14.
"GISAID hCOV19 Variants (see menu option 'G/484K.V3 (B.1.525)')". www.gisaid.org. สืบค้นเมื่อ 2021-03-04.{{cite web}}: CS1 maint: url-status (ลิงก์)

github.com

"Date mismatch between international report and lineage description - cov-lineages/pangolin". GitHub (Software issue). 2021-06-13. สืบค้นเมื่อ 2021-06-14.
"cov-lineages/pangolin: Software package for assigning SARS-CoV-2 genome sequences to global lineages". Github. สืบค้นเมื่อ 2021-01-02.

globalnews.ca

Pearson, Heide; Pullen, Lauren; Dao, Christa (2021-06-11). "AHS breaks down vaccination data of COVID-19 Delta variant outbreak at Calgary hospital". Global News. สืบค้นเมื่อ 2021-06-12.

gmanetwork.com

"Duterte says Sulu seeking help after new COVID-19 variant detected in nearby Sabah, Malaysia". GMA News (ภาษาอังกฤษ). 2020-12-27. สืบค้นเมื่อ 2021-01-10.

gov.uk

"Variants: distribution of cases data". GOV.UK. Government Digital Service. Public Health England.
"Investigation of SARS-CoV-2 variants of concern: technical briefings". GOV.UK. Government Digital Service. Public Health England.
"Investigation of SARS-CoV-2 variants of concern: variant risk assessments". GOV.UK. Government Digital Service. Public Health England.
Horby, Peter; Barclay, Wendy; Huntley, Catherine (2021-01-13). NERVTAG paper: brief note on SARS-CoV-2 variants (Note). Public Health England. สืบค้นเมื่อ 2021-06-06.
"Confirmed cases of COVID-19 variants identified in UK". Friday 15 January: GOV.UK. Public Health England. 2021-01-15.{{cite news}}: CS1 maint: location (ลิงก์)
Horby, Peter; Barclay, Wendy; Gupta, Ravi; Huntley, Catherine (2021-01-27). NERVTAG paper: note on variant P.1 (Note). Public Health England. สืบค้นเมื่อ 2021-06-06.
Public Health England (2021-02-16). "Variants: distribution of cases data". GOV.UK. สืบค้นเมื่อ 2021-02-17.{{cite web}}: CS1 maint: url-status (ลิงก์)
"PHE investigating a novel strain of COVID-19". Public Health England (PHE). 2020-12-14.
"Latest update: New Variant Under Investigation designated in the UK". www.gov.uk. 2021-03-04. สืบค้นเมื่อ 2021-03-05.

harvard.edu

ui.adsabs.harvard.edu

Singh, A; Steinkellner, G; Köchl, K; Gruber, K; Gruber, CC (February 2021). "Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2". Scientific Reports. 11 (1): 4320. Bibcode:2021NatSR..11.4320S. doi:10.1038/s41598-021-83761-5. PMC 7900180. PMID 33619331.
Kupferschmidt, K (January 2021). "New mutations raise specter of 'immune escape'". Science. 371 (6527): 329–330. Bibcode:2021Sci...371..329K. doi:10.1126/science.371.6527.329. PMID 33479129.
Hou, YJ; Chiba, S; Halfmann, P; Ehre, C; Kuroda, M; Dinnon, KH; และคณะ (December 2020). "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo". Science. 370 (6523): 1464–1468. Bibcode:2020Sci...370.1464H. doi:10.1126/science.abe8499. PMC 7775736. PMID 33184236. an emergent Asp614→Gly (D614G) substitution in the spike glycoprotein of SARS-CoV-2 strains that is now the most prevalent form globally
McCarthy, KR; Rennick, LJ; Nambulli, S; Robinson-McCarthy, LR; Bain, WG; Haidar, G; Duprex, WP (March 2021). "Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape". Science. 371 (6534): 1139–1142. Bibcode:2021Sci...371.1139M. doi:10.1126/science.abf6950. PMC 7971772. PMID 33536258.
Muik, A; Wallisch, AK; Sänger, B; Swanson, KA; Mühl, J; Chen, W; และคณะ (March 2021). "Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera". Science. 371 (6534): 1152–53. Bibcode:2021Sci...371.1152M. doi:10.1126/science.abg6105. PMC 7971771. PMID 33514629.
Wang, P; Nair, MS; Liu, L; Iketani, S; Luo, Y; Guo, Y; และคณะ (March 2021). "Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7". Nature. 593 (7857): 130–35. Bibcode:2021Natur.593..130W. doi:10.1038/s41586-021-03398-2. PMID 33684923.

i-base.info

"escape mutation". HIV i-Base. 2012-10-11. สืบค้นเมื่อ 2021-02-19.

indiatoday.in

Sharma, Milan. "New 'Delta Plus' variant of SARS-CoV-2 identified; here's what we know so far". India Today (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-06-16.
"What is the new 'triple mutant variant' of Covid-19 virus found in Bengal? How bad is it?". indiatoday. 2021-04-22.

innophore.com

"Coronavirus SARS-CoV-2 (formerly known as Wuhan coronavirus and 2019-nCoV) - what we can find out on a structural bioinformatics level". Innophore (ภาษาอังกฤษแบบอเมริกัน). 2020-01-23. สืบค้นเมื่อ 2021-02-22.

irishtimes.com

- Cullen, P (2021-02-25). "Coronavirus: Variant discovered in UK and Nigeria found in State for first time". The Irish Times. สืบค้นเมื่อ 2021-02-25.

japantoday.com

"Japan finds new coronavirus variant in travelers from Brazil". Japan Today. Japan. 2021-01-11. สืบค้นเมื่อ 2021-01-14.

jnj.com

"Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial" (Press release). Johnson & Johnson. 2021-01-29. สืบค้นเมื่อ 2021-01-29.

khub.net

"New evidence on VUI-202012/01 and review of the public health risk assessment". khub.net. 2020-12-15.
"New evidence on VUI-202012/01 and review of the public health risk assessment". สืบค้นเมื่อ 2021-01-04.

livescience.com

Rettner, R (2021-02-02). "UK coronavirus variant develops vaccine-evading mutation - In a handful of instances, the U.K. coronavirus variant has developed a mutation called E484K, which may impact vaccine effectiveness". Live Science. สืบค้นเมื่อ 2021-02-02.

lrt.lt

"Unidentified coronavirus strain found in eastern Lithuania". lrt.lt. 2021-04-20.

mdpi.com

Shahhosseini, Nariman; Babuadze, George; Wong, Gary; Kobinger, Gary (2021). "Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern". Microorganisms. 9 (5): 926. doi:10.3390/microorganisms9050926. PMID 33925854. S2CID 233460887. สืบค้นเมื่อ 2021-05-04.

medicalxpress.com

"New, more infectious strain of COVID-19 now dominates global cases of virus: study". medicalxpress.com (ภาษาอังกฤษ). เก็บจากแหล่งเดิมเมื่อ 2020-11-17. สืบค้นเมื่อ 2020-08-16.

medrxiv.org

Coutinho, RM; Marquitti, FM; Ferreira, LS; Borges, ME; da Silva, RL; Canton, O; และคณะ (2021-03-23). "Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant". medRxiv (Preprint): 9. doi:10.1101/2021.03.03.21252706. S2CID 232119656. สืบค้นเมื่อ 2021-04-29. The new variant was found to be about 2.6 times more transmissible (95% Confidence Interval (CI): 2.4-2.8) than previous circulating variant (s). ... Table 1: Summary of the fitted parameters and respective confidence intervals considering the entire period, November 1, 2020-January 31, 2021 maintaining the same pathogenicity of the previous variant. Parameter: Relative transmission rate for the new variant. Estimate: 2.61. 2.5%: 2.45. 97.5%: 2.76.
Freitas, AR; Lemos, DR; Beckedorff, OA; Cavalcanti, LP; Siqueira, AM; Mello, RC; และคณะ (2021-04-19). "The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions" (Preprint). doi:10.1101/2021.04.13.21255281 – โดยทาง medRxiv. Female 20 to 39 years old, with no pre-existing risk conditions, were at risk of death 5.65 times higher in February (95% CI, 2.9-11.03; p <0.0001) and in the age group of 40 and 59 years old, this risk was 7.7 times higher (95% CI, 5.01-11.83; p <0.0001) comparing with November-December. ... The heterogeneity observed between the age groups was greater when we analyzed the subgroup of the population without preexisting risk conditions where we found that the CFR in the female sex in the second wave was 1.95 times (95% CI, 1.38-2.76) the CFR of the first wave in the population over 85 years old and was 7.7 times (95% CI, 5.01-11.83; p < 0.0001) in the population between 40 and 59 years old. In the male population without previous diseases, the CFR in the second wave was 2.18 (95% CI, 1.62-2.93) times the CFR of the first wave in the population over 85 years old and 5.9 (95% CI, 3.2-10.85; p < 0, 0001) higher in the range between 20 and 39 years old. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Deng, X; Garcia-Knight, MA; Khalid, MM; Servellita, V; Wang, C; Morris, MK; และคณะ (2021-03-09). "Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation" (Preprint). doi:10.1101/2021.03.07.21252647. PMC 7987058. PMID 33758899 – โดยทาง medRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Ito, K; Piantham, C; Nishiura, H (2021-06-15). "Predicted domination of variant Delta of SARS-CoV-2 before Tokyo Olympic games, Japan". medRxiv (Preprint). doi:10.1101/2021.06.12.21258835. S2CID 235437370.
Zhang, W; Davis, B; Chen, SS; Martinez, JS; Plummer, JT; Vail, E (2021). "Emergence of a novel SARS-CoV-2 strain in Southern California, USA". MedRxiv. doi:10.1101/2021.01.18.21249786. S2CID 231646931.
Voloch, CM; da Silva Francisco, R; de Almeida, LG; Cardoso, CC; Brustolini, OJ; Gerber, AL; และคณะ (2020). "Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil". doi:10.1101/2020.12.23.20248598. S2CID 229379623 – โดยทาง MedRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Garcia-Beltran, W; Lam, E; Denis, K (2021-03-12). "Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity". doi:10.1101/2021.02.14.21251704. สืบค้นเมื่อ 2021-04-14 – โดยทาง medrxiv.

moh.gov.my

covid-19.moh.gov.my

"The current situation and Information on the Spike protein mutation of Covid-19 in Malaysia". Kementerian Kesihatan Malaysia/ covid-19 Malaysia/ covid-19.moh.gov.my. 2020-12-25. สืบค้นเมื่อ 2021-01-15.
"The current situation and Information on the Spike protein mutation of Covid-19 in Malaysia". Ministry of Health (Malaysia). 2020-12-25.
"Variants of Concerns (VOC), B.1.524, B.1.525, South African B.1.351, STRAIN D614G, A701V, B1.1.7". Department of Health, Malaysia. 2021-04-14.

nccid.ca

Griffiths, E; Tanner, J; Knox, N; Hsiao, W; Van Domselaar, G (2021-01-15). "CanCOGeN Interim Recommendations for Naming, Identifying,and Reporting SARS-CoV-2 Variants of Concern" (PDF). CanCOGeN (nccid.ca). สืบค้นเมื่อ 2021-02-25.

news-medical.net

"The ancestor of SARS-CoV-2's Wuhan strain was circulating in late October 2019". News Medical. สืบค้นเมื่อ 2020-05-10. Journal reference: Kumar, S. et al. (2021). An evolutionary portrait...{{cite web}}: CS1 maint: url-status (ลิงก์)
"The travel-related origin and spread of SARS-CoV-2 B.1.620 strain". 2021-05-11.
Greenwood, M (2021-01-15). ""What Mutations of SARS-CoV-2 are Causing Concern?"]". News Medical Lifesciences. สืบค้นเมื่อ 2021-01-16.
"Study shows P681H mutation is becoming globally prevalent among SARS-CoV-2 sequences". News-Medical.net (ภาษาอังกฤษ). 2021-01-10. สืบค้นเมื่อ 2021-02-11.

newscientist.com

Le Page, Michael (2021-06-04). "Indian covid-19 variant (B.1.617)". New Scientist. สืบค้นเมื่อ 2021-06-08.

newswise.com

"Local COVID-19 Strain Found in Over One-Third of Los Angeles Patients". news wise (Press release). California: Cedars Sinai Medical Center. 2021-01-19. สืบค้นเมื่อ 2021-03-03.

nextstrain.org

clades.nextstrain.org

"Nextclade" (What are the clades?). clades.nextstrain.org. เก็บจากแหล่งเดิมเมื่อ 2021-01-19. สืบค้นเมื่อ 2021-01-19.

nextstrain.org

Bedford, T; Hodcroft, B; Neher, RA (2021-01-06). "Updated Nextstrain SARS-CoV-2 clade naming strategy". nextstrain.org/blog. สืบค้นเมื่อ 2021-01-19.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shahhosseini, Nariman; Babuadze, George; Wong, Gary; Kobinger, Gary (2021). "Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern". Microorganisms. 9 (5): 926. doi:10.3390/microorganisms9050926. PMID 33925854. S2CID 233460887. สืบค้นเมื่อ 2021-05-04.
Shahhosseini, Nariman; Wong, Gary; Kobinger, Gary; Chinikar, Sadegh (2021). "SARS-CoV-2 spillover transmission due to recombination event". Gene Reports. 23: 101045. doi:10.1016/j.genrep.2021.101045. PMC 7884226. PMID 33615041.
Yurkovetskiy, Leonid; Wang, Xue; Pascal, Kristen E.; Tomkins-Tinch, Christopher; Nyalile, Thomas P.; Wang, Yetao; และคณะ (October 2020). "Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant". Cell. 183 (3): 739-751.e8. doi:10.1016/j.cell.2020.09.032. PMC 7492024. PMID 32991842.
Thomson, Emma C.; Rosen, Laura E.; Shepherd, James G.; Spreafico, Roberto; da Silva Filipe, Ana; Wojcechowskyj, Jason A.; และคณะ (March 2021). "Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity". Cell. 184 (5): 1171-1187.e20. doi:10.1016/j.cell.2021.01.037. PMC 7843029. PMID 33621484.
Davies, NG; Abbott, S; Barnard, RC; Jarvis, CI; Kucharski, AJ; Munday, JD; และคณะ (2021). "Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England". Science. 372 (6538): eabg3055. doi:10.1126/science.abg3055. PMC 8128288. PMID 33658326.{{cite journal}}: CS1 maint: multiple names: authors list (ลิงก์)
Nyberg, T; Twohig, KA; Harris, RJ; Seaman, SR; Flannagan, J; Allen, H; และคณะ (2021-06-15). "Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis". BMJ. 373: n1412. doi:10.1136/bmj.n1412. ISSN 1756-1833. PMID 34130987. S2CID 235187479.
Zhao, S; Lou, J; Cao, L; Zheng, H; Chong, MK; Chen, Z; และคณะ (2021-01-28). "Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis". Journal of Travel Medicine. 28 (2). doi:10.1093/jtm/taab011. ISSN 1195-1982. PMC 7928809. PMID 33506254.
Faria, NR; Mellan, TA; Whittaker, C; Claro, IM; Candido, DS; Mishra, S; และคณะ (2021-05-21). "Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil". Science. 372 (6544): 815–821. doi:10.1126/science.abh2644. ISSN 0036-8075. PMID 33853970. Within this plausible region of parameter space, P.1 can be between 1.7 and 2.4 times more transmissible (50% BCI, 2.0 median, with a 99% posterior probability of being >1) than local non-P1 lineages and can evade 21 to 46% (50% BCI, 32% median, with a 95% posterior probability of being able to evade at least 10%) of protective immunity elicited by previous infection with non-P.1 lineages, corresponding to 54 to 79% (50% BCI, 68% median) cross-immunity ... We estimate that infections are 1.2 to 1.9 times more likely (50% BCI, median 1.5, 90% posterior probability of being >1) to result in mortality in the period after the emergence of P.1, compared with before, although posterior estimates of this relative risk are also correlated with inferred cross-immunity. More broadly, the recent epidemic in Manaus has strained the city’s health care system, leading to inadequate access to medical care. We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus health care system, or both. Detailed clinical investigations of P.1 infections are needed.
Collier, DA; De Marco, A; Gupta, RK; al, et (2021-05-06). "Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies". Nature (Published). 593 (7857): 136–141. doi:10.1038/s41586-021-03412-7. PMID 33706364. We therefore generated pseudoviruses that carried the B.1.1.7 spike mutations with or without the additional E484K substitution and tested these against sera obtained after the first and second dose of the BNT162b2 mRNA vaccine as well as against convalescent sera. After the second vaccine dose, we observed a considerable loss of neutralizing activity for the pseudovirus with the B.1.1.7 spike mutations and E484K (Fig. 3d, e). The mean fold change for the E484K-containing B.1.1.7 spike variant was 6.7 compared with 1.9 for the B.1.1.7 variant, relative to the wild-type spike protein (Fig. 3a-c and Extended Data Fig. 5). Similarly, when we tested a panel of convalescent sera with a range of neutralization titres (Fig. 1f, g and Extended Data Fig. 5), we observed additional loss of activity against the mutant B.1.1.7 spike with E484K, with fold change of 11.4 relative to the wild-type spike protein (Fig. 3f, g and Extended Data Fig. 5).
Deng, X; Garcia-Knight, MA; Khalid, MM; Servellita, V; Wang, C; Morris, MK; และคณะ (2021-03-09). "Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation" (Preprint). doi:10.1101/2021.03.07.21252647. PMC 7987058. PMID 33758899 – โดยทาง medRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Sheikh, A; McMenamin, J; Taylor, B; Robertson, C (2021-06-14). "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness". The Lancet. doi:10.1016/S0140-6736(21)01358-1. ISSN 0140-6736. PMID 34139198.
Yadav, PD; Sapkal, GN; Abraham, P; Ella, R; Deshpande, G; Patil, DY; และคณะ (2021-05-07). "Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees". Clinical Infectious Diseases. Oxford University Press (ciab411). bioRxiv 10.1101/2021.04.23.441101. doi:10.1093/cid/ciab411. PMID 33961693.
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (November 2020). "A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 5 (11): 1403–1407. doi:10.1038/s41564-020-0770-5. PMC 7610519. PMID 32669681. S2CID 220544096. Cited in Alm et al.
Alm, E; Broberg, EK; Connor, T; Hodcroft, EB; Komissarov, AB; Maurer-Stroh, S; และคณะ (August 2020). "Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020". Euro Surveillance. 25 (32). doi:10.2807/1560-7917.ES.2020.25.32.2001410. PMC 7427299. PMID 32794443.
Zhukova, A; Blassel, L; Lemoine, F; Morel, M; Voznica, J; Gascuel, O (November 2020). "Origin, evolution and global spread of SARS-CoV-2". Comptes Rendus Biologies: 1–20. doi:10.5802/crbiol.29. PMID 33274614.
Koyama, T; Platt, D; Parida, L (July 2020). "Variant analysis of SARS-CoV-2 genomes". Bulletin of the World Health Organization. 98 (7): 495–504. doi:10.2471/BLT.20.253591. PMC 7375210. PMID 32742035. We detected in total 65776 variants with 5775 distinct variants.
Hadfield, J; Megill, C; Bell, SM; Huddleston, J; Potter, B; Callender, C; และคณะ (December 2018). Kelso, J (บ.ก.). "Nextstrain: real-time tracking of pathogen evolution". Bioinformatics. 34 (23): 4121–4123. doi:10.1093/bioinformatics/bty407. PMC 6247931. PMID 29790939.
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (March 2021). "Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 6 (3): 415. doi:10.1038/s41564-021-00872-5. PMC 7845574. PMID 33514928.
Chiara, M; Horner, DS; Gissi, C; Pesole, G (May 2021). "Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2". Mol Biol Evol. 38 (6): 2547–2565. doi:10.1093/molbev/msab049. PMC 7928790. PMID 33605421.
Chen, RE; Zhang, X; Case, JB; Winkler, ES; Liu, Y; VanBlargan, LA; และคณะ (March 2021). "Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies". Nature Medicine. 27 (4): 717–726. doi:10.1038/s41591-021-01294-w. PMC 8058618. PMID 33664494.
Shen, X; Tang, H; Pajon, R; Smith, G; Glenn, GM; Shi, W; และคณะ (April 2021). "Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351". The New England Journal of Medicine. doi:10.1056/NEJMc2103740. PMC 8063884. PMID 33826819.
Larsen, HD; Fonager, J; Lomholt, FK; Dalby, T; Benedetti, G; Kristensen, B; และคณะ (February 2021). "Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020". Euro Surveillance. 26 (5). doi:10.2807/1560-7917.ES.2021.26.5.210009. PMC 7863232. PMID 33541485.
Singh, A; Steinkellner, G; Köchl, K; Gruber, K; Gruber, CC (February 2021). "Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2". Scientific Reports. 11 (1): 4320. Bibcode:2021NatSR..11.4320S. doi:10.1038/s41598-021-83761-5. PMC 7900180. PMID 33619331.
Wise, J (February 2021). "Covid-19: The E484K mutation and the risks it poses". BMJ. 372: n359. doi:10.1136/bmj.n359. PMID 33547053. S2CID 231821685.
Kupferschmidt, K (January 2021). "New mutations raise specter of 'immune escape'". Science. 371 (6527): 329–330. Bibcode:2021Sci...371..329K. doi:10.1126/science.371.6527.329. PMID 33479129.
Maison, DP; Ching, LL; Shikuma, CM; Nerurkar, VR (January 2021). "Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation". bioRxiv: 2021.01.06.425497. doi:10.1101/2021.01.06.425497. PMC 7805472. PMID 33442699. Available under CC BY 4.0.
Korber, B; Fischer, WM; Gnanakaran, S; Yoon, H; Theiler, J; Abfalterer, W; และคณะ (August 2020). "Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus". Cell. 182 (4): 812-827.e19. doi:10.1016/j.cell.2020.06.043. PMC 7332439. PMID 32697968.
Hou, YJ; Chiba, S; Halfmann, P; Ehre, C; Kuroda, M; Dinnon, KH; และคณะ (December 2020). "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo". Science. 370 (6523): 1464–1468. Bibcode:2020Sci...370.1464H. doi:10.1126/science.abe8499. PMC 7775736. PMID 33184236. an emergent Asp614→Gly (D614G) substitution in the spike glycoprotein of SARS-CoV-2 strains that is now the most prevalent form globally
Butowt, R; Bilinska, K; Von Bartheld, CS (October 2020). "Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor". ACS Chemical Neuroscience. 11 (20): 3180–3184. doi:10.1021/acschemneuro.0c00596. PMC 7581292. PMID 32997488.
McCarthy, KR; Rennick, LJ; Nambulli, S; Robinson-McCarthy, LR; Bain, WG; Haidar, G; Duprex, WP (March 2021). "Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape". Science. 371 (6534): 1139–1142. Bibcode:2021Sci...371.1139M. doi:10.1126/science.abf6950. PMC 7971772. PMID 33536258.
Burioni, R; Topol, EJ (2021-06-21). "Has SARS-CoV-2 reached peak fitness?". Nature Medicine. doi:10.1038/s41591-021-01421-7. PMID 34155413.
Mahase, E (March 2021). "Covid-19: Where are we on vaccines and variants?". BMJ. 372: n597. doi:10.1136/bmj.n597. PMID 33653708. S2CID 232093175.
Muik, A; Wallisch, AK; Sänger, B; Swanson, KA; Mühl, J; Chen, W; และคณะ (March 2021). "Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera". Science. 371 (6534): 1152–53. Bibcode:2021Sci...371.1152M. doi:10.1126/science.abg6105. PMC 7971771. PMID 33514629.
Wang, P; Nair, MS; Liu, L; Iketani, S; Luo, Y; Guo, Y; และคณะ (March 2021). "Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7". Nature. 593 (7857): 130–35. Bibcode:2021Natur.593..130W. doi:10.1038/s41586-021-03398-2. PMID 33684923.
Mahase, E (February 2021). "Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant". BMJ. 372: n296. doi:10.1136/bmj.n296. PMID 33526412. S2CID 231730012.
Liu, Y; Liu, J; Xia, H; Zhang, X; Fontes-Garfias, CR; Swanson, KA; และคณะ (February 2021). "Neutralizing Activity of BNT162b2-Elicited Serum - Preliminary Report". The New England Journal of Medicine. doi:10.1056/nejmc2102017. PMID 33596352.
Hoffmann, M; Arora, P; Gross, R; Seidel, A; Hoernich, BF; Hahn, AS; และคณะ (March 2021). "1 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies". Cell. 184 (9): 2384-2393.e12. doi:10.1016/j.cell.2021.03.036. PMC 7980144. PMID 33794143.

ncbi.nlm.nih.gov

Shahhosseini, Nariman; Wong, Gary; Kobinger, Gary; Chinikar, Sadegh (2021). "SARS-CoV-2 spillover transmission due to recombination event". Gene Reports. 23: 101045. doi:10.1016/j.genrep.2021.101045. PMC 7884226. PMID 33615041.
Yurkovetskiy, Leonid; Wang, Xue; Pascal, Kristen E.; Tomkins-Tinch, Christopher; Nyalile, Thomas P.; Wang, Yetao; และคณะ (October 2020). "Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant". Cell. 183 (3): 739-751.e8. doi:10.1016/j.cell.2020.09.032. PMC 7492024. PMID 32991842.
Thomson, Emma C.; Rosen, Laura E.; Shepherd, James G.; Spreafico, Roberto; da Silva Filipe, Ana; Wojcechowskyj, Jason A.; และคณะ (March 2021). "Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity". Cell. 184 (5): 1171-1187.e20. doi:10.1016/j.cell.2021.01.037. PMC 7843029. PMID 33621484.
Davies, NG; Abbott, S; Barnard, RC; Jarvis, CI; Kucharski, AJ; Munday, JD; และคณะ (2021). "Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England". Science. 372 (6538): eabg3055. doi:10.1126/science.abg3055. PMC 8128288. PMID 33658326.{{cite journal}}: CS1 maint: multiple names: authors list (ลิงก์)
Zhao, S; Lou, J; Cao, L; Zheng, H; Chong, MK; Chen, Z; และคณะ (2021-01-28). "Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis". Journal of Travel Medicine. 28 (2). doi:10.1093/jtm/taab011. ISSN 1195-1982. PMC 7928809. PMID 33506254.
Deng, X; Garcia-Knight, MA; Khalid, MM; Servellita, V; Wang, C; Morris, MK; และคณะ (2021-03-09). "Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation" (Preprint). doi:10.1101/2021.03.07.21252647. PMC 7987058. PMID 33758899 – โดยทาง medRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (November 2020). "A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 5 (11): 1403–1407. doi:10.1038/s41564-020-0770-5. PMC 7610519. PMID 32669681. S2CID 220544096. Cited in Alm et al.
Alm, E; Broberg, EK; Connor, T; Hodcroft, EB; Komissarov, AB; Maurer-Stroh, S; และคณะ (August 2020). "Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020". Euro Surveillance. 25 (32). doi:10.2807/1560-7917.ES.2020.25.32.2001410. PMC 7427299. PMID 32794443.
Koyama, T; Platt, D; Parida, L (July 2020). "Variant analysis of SARS-CoV-2 genomes". Bulletin of the World Health Organization. 98 (7): 495–504. doi:10.2471/BLT.20.253591. PMC 7375210. PMID 32742035. We detected in total 65776 variants with 5775 distinct variants.
Hadfield, J; Megill, C; Bell, SM; Huddleston, J; Potter, B; Callender, C; และคณะ (December 2018). Kelso, J (บ.ก.). "Nextstrain: real-time tracking of pathogen evolution". Bioinformatics. 34 (23): 4121–4123. doi:10.1093/bioinformatics/bty407. PMC 6247931. PMID 29790939.
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (March 2021). "Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 6 (3): 415. doi:10.1038/s41564-021-00872-5. PMC 7845574. PMID 33514928.
Chiara, M; Horner, DS; Gissi, C; Pesole, G (May 2021). "Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2". Mol Biol Evol. 38 (6): 2547–2565. doi:10.1093/molbev/msab049. PMC 7928790. PMID 33605421.
Chen, RE; Zhang, X; Case, JB; Winkler, ES; Liu, Y; VanBlargan, LA; และคณะ (March 2021). "Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies". Nature Medicine. 27 (4): 717–726. doi:10.1038/s41591-021-01294-w. PMC 8058618. PMID 33664494.
Shen, X; Tang, H; Pajon, R; Smith, G; Glenn, GM; Shi, W; และคณะ (April 2021). "Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351". The New England Journal of Medicine. doi:10.1056/NEJMc2103740. PMC 8063884. PMID 33826819.
Larsen, HD; Fonager, J; Lomholt, FK; Dalby, T; Benedetti, G; Kristensen, B; และคณะ (February 2021). "Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020". Euro Surveillance. 26 (5). doi:10.2807/1560-7917.ES.2021.26.5.210009. PMC 7863232. PMID 33541485.
Singh, A; Steinkellner, G; Köchl, K; Gruber, K; Gruber, CC (February 2021). "Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2". Scientific Reports. 11 (1): 4320. Bibcode:2021NatSR..11.4320S. doi:10.1038/s41598-021-83761-5. PMC 7900180. PMID 33619331.
Maison, DP; Ching, LL; Shikuma, CM; Nerurkar, VR (January 2021). "Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation". bioRxiv: 2021.01.06.425497. doi:10.1101/2021.01.06.425497. PMC 7805472. PMID 33442699. Available under CC BY 4.0.
Korber, B; Fischer, WM; Gnanakaran, S; Yoon, H; Theiler, J; Abfalterer, W; และคณะ (August 2020). "Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus". Cell. 182 (4): 812-827.e19. doi:10.1016/j.cell.2020.06.043. PMC 7332439. PMID 32697968.
Hou, YJ; Chiba, S; Halfmann, P; Ehre, C; Kuroda, M; Dinnon, KH; และคณะ (December 2020). "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo". Science. 370 (6523): 1464–1468. Bibcode:2020Sci...370.1464H. doi:10.1126/science.abe8499. PMC 7775736. PMID 33184236. an emergent Asp614→Gly (D614G) substitution in the spike glycoprotein of SARS-CoV-2 strains that is now the most prevalent form globally
Butowt, R; Bilinska, K; Von Bartheld, CS (October 2020). "Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor". ACS Chemical Neuroscience. 11 (20): 3180–3184. doi:10.1021/acschemneuro.0c00596. PMC 7581292. PMID 32997488.
McCarthy, KR; Rennick, LJ; Nambulli, S; Robinson-McCarthy, LR; Bain, WG; Haidar, G; Duprex, WP (March 2021). "Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape". Science. 371 (6534): 1139–1142. Bibcode:2021Sci...371.1139M. doi:10.1126/science.abf6950. PMC 7971772. PMID 33536258.
Muik, A; Wallisch, AK; Sänger, B; Swanson, KA; Mühl, J; Chen, W; และคณะ (March 2021). "Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera". Science. 371 (6534): 1152–53. Bibcode:2021Sci...371.1152M. doi:10.1126/science.abg6105. PMC 7971771. PMID 33514629.
Hoffmann, M; Arora, P; Gross, R; Seidel, A; Hoernich, BF; Hahn, AS; และคณะ (March 2021). "1 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies". Cell. 184 (9): 2384-2393.e12. doi:10.1016/j.cell.2021.03.036. PMC 7980144. PMID 33794143.

niid.go.jp

"Brief report: New Variant Strain of SARS-CoV-2 Identified in Travelers from Brazil" (PDF) (Press release). Japan: NIID (National Institute of Infectious Diseases). 2021-01-12. สืบค้นเมื่อ 2021-01-14.

npr.org

"People Are Talking About A 'Double Mutant' Variant In India. What Does That Mean?". NPR.org (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-04-27. ...scientifically, the term "double mutant" makes no sense, Andersen says. "SARS-CoV-2 mutates all the time. So there are many double mutants all over the place. The variant in India really shouldn't be called that."

nsw.gov.au

aci.health.nsw.gov.au

"Living Evidence - SARS-CoV-2 variants". Agency for Clinical Innovation. nsw.gov.au. Ministry of Health (New South Wales). 2021-06-22. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-16. สืบค้นเมื่อ 2021-06-09.

nytimes.com

Zimmer, Carl; Mandavilli, Apoorva (2021-05-14). "How the United States Beat the Variants, for Now". New York Times. สืบค้นเมื่อ 2021-05-17.
Mandavilli, A (2021-03-05). "In Oregon, Scientists Find a Virus Variant With a Worrying Mutation - In a single sample, geneticists discovered a version of the coronavirus first identified in Britain with a mutation originally reported in South Africa". The New York Times. สืบค้นเมื่อ 2021-03-06.
"South Africa announces a new coronavirus variant". The New York Times. 2020-12-18. สืบค้นเมื่อ 2020-12-20.
Andreoni, M; Londoño, E; Casado, L (2021-03-03). "Brazil's Covid Crisis Is a Warning to the Whole World, Scientists Say - Brazil is seeing a record number of deaths, and the spread of a more contagious coronavirus variant that may cause reinfection". The New York Times. สืบค้นเมื่อ 2021-03-03.
Zimmer, C (2021-03-01). "Virus Variant in Brazil Infected Many Who Had Already Recovered From Covid-19 - The first detailed studies of the so-called P.1 variant show how it devastated a Brazilian city. Now scientists want to know what it will do elsewhere". The New York Times. สืบค้นเมื่อ 2021-03-03.
"New California Variant May Be Driving Virus Surge There, Study Suggests". New York Times. 2021-01-19.
Mandavilli, A (2021-02-24). "A New Coronavirus Variant Is Spreading in New York, Researchers Report". The New York Times.
Mandavilli, A; Mueller, B (2021-03-02). "Why Virus Variants Have Such Weird Names". The New York Times. ISSN 0362-4331. สืบค้นเมื่อ 2021-03-02.
"Inside the B.1.1.7 Coronavirus Variant". The New York Times. 2021-01-18. สืบค้นเมื่อ 2021-01-29.

osu.edu

wexnermedical.osu.edu

"Researchers Discover New Variant of COVID-19 Virus in Columbus, Ohio". wexnermedical.osu.edu. 2021-01-13. สืบค้นเมื่อ 2021-01-16.

oup.com

academic.oup.com

Kumar, Sudhir; Tao, Qiqing; Weaver, Steven; Sanderford, Maxwell; Caraballo-Ortiz, Marcos A; Sharma, Sudip; Pond, Sergei L K; Miura, Sayaka. "An evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic". Oxford Academic. สืบค้นเมื่อ 2020-05-10.{{cite web}}: CS1 maint: url-status (ลิงก์)
Yadav, PD; Sapkal, GN; Abraham, P; Ella, R; Deshpande, G; Patil, DY; และคณะ (2021-05-07). "Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees". Clinical Infectious Diseases. Oxford University Press (ciab411). bioRxiv 10.1101/2021.04.23.441101. doi:10.1093/cid/ciab411. PMID 33961693.

outbreak.info

"B.1.1.7 Lineage with S:E484K Report". outbreak.info. 2021-03-05. สืบค้นเมื่อ 2021-03-07.
B.1.1.7 Lineage with S:E484K Report, outbreak.info
B.1.429 Lineage Report. Alaa Abdel Latif, Julia L. Mullen, Manar Alkuzweny, Ginger Tsueng, Marco Cano, Emily Haag, Jerry Zhou, Mark Zeller, Nate Matteson, Chunlei Wu, Kristian G. Andersen, Andrew I. Su, Karthik Gangavarapu, Laura D. Hughes, and the Center for Viral Systems Biology. outbreak.info, (available at https://outbreak.info/situation-reports?pango=B.1.429&loc=USA&loc=USA_US-CA&selected=USA_US-CA). Accessed 28 May 2021.
"B.1.429 Lineage Report". Scripps Research. outbreak.info. 2021-02-15. สืบค้นเมื่อ 2021-02-16.

pfizer.com

"Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study". Pfizer (Press release). 2021-04-01. สืบค้นเมื่อ 2021-04-02.

publishing.service.gov.uk

assets.publishing.service.gov.uk

"SARS-CoV-2 variants: risk assessment framework" (PDF). GOV.UK. Government Digital Service. Public Health England. 2021-05-22. GOV-8426.
Investigation of novel SARS-COV-2 variant, technical briefing 1 (PDF) (Briefing). Public Health England. 2020-12-21. สืบค้นเมื่อ 2021-06-06.
Investigation of novel SARS-CoV-2 variant 202012/01, technical briefing 5 (PDF) (Briefing). Public Health England. 2021-02-02. GW-1905. สืบค้นเมื่อ 2021-06-14.
Investigation of SARS-CoV-2 variants of concern in England, technical briefing 6 (PDF) (Briefing). Public Health England. 2021-02-13. GW-1934. สืบค้นเมื่อ 2021-06-06.
SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 10 (PDF) (Briefing). Public Health England. 2021-05-07. GOV-8226. สืบค้นเมื่อ 2021-06-06.
SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 15 (PDF) (Briefing). Public Health England. 2021-06-11. GOV-8576. สืบค้นเมื่อ 2021-06-15.
Risk assessment for SARS-CoV-2 variant Delta (PDF) (Assessment). Public Health England. 2021-06-18. GOV-8664. สืบค้นเมื่อ 2021-06-22.
Chand, M; Hopkins, S; Dabrera, G; Achison, C; Barclay, W; Ferguson, N; และคณะ (2020-12-21). Investigation of novel SARS-COV-2 variant: Variant of Concern 202012/01 (PDF) (Report). Public Health England. สืบค้นเมื่อ 2020-12-23.
Horby, Peter; Huntley, Catherine; Davies, Nick; Edmunds, John; Ferguson, Neil; Medley, Graham; Hayward, Andrew; Cevik, Muge; Semple, Calum (2021-02-11). "NERVTAG paper on COVID-19 variant of concern B.1.1.7: NERVTAG update note on B.1.1.7 severity (2021-02-11)" (PDF). www.gov.uk.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)
SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 16 (PDF) (Briefing). Public Health England. 2021-06-18. GOV-8641. สืบค้นเมื่อ 2021-06-23.
SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 10 (PDF) (Report) (ภาษาอังกฤษ). London. Public Health England. 2021-05-07. สืบค้นเมื่อ 2021-06-05. A variant first detected in India was designated under investigation on 1 April 2021 as VUI-21APR-01 (B.1.617.1). OGL บทความนี้ รวมเนื้อความที่ตีพิมพ์ใต้สัญญา Open Government Licence v3.0:
"Technical briefing 5" (PDF). Gov.uk. Public Health England. p. 17. สืบค้นเมื่อ 2021-02-02.

researchsquare.com

Nascimento, V; Souza, V (2021-02-25). "COVID-19 epidemic in the Brazilian state of Amazonas was driven by long-term persistence of endemic SARS-CoV-2 lineages and the recent emergence of the new Variant of Concern P.1". Research Square. doi:10.21203/rs.3.rs-275494/v1. สืบค้นเมื่อ 2021-03-02. {{cite journal}}: Cite journal ต้องการ |journal= (help)

reuters.com

Gaier, R (2021-03-05). "Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says". Reuters. Rio de Janeiro. สืบค้นเมื่อ 2021-03-09.
"Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says". Reuters. Rio de Janeiro. 2021-03-08. สืบค้นเมื่อ 2021-03-09.
"British scientists warn over Indian coronavirus variant". Reuters. 2021-05-07. สืบค้นเมื่อ 2021-05-07.
Acharya, Bhargav; Jamkhandikar, Shilpa (2021-06-23). "Explainer: What is the Delta variant of coronavirus with K417N mutation?". Reuters. สืบค้นเมื่อ 2021-06-23.
"India says new COVID variant is a concern". Reuters. Bengaluru. 2021-06-22. สืบค้นเมื่อ 2021-06-23.
Smout, A (2021-01-26). "Britain to help other countries track down coronavirus variants". www.reuters.com. สืบค้นเมื่อ 2021-01-27.
Francis, D; Andy, B (2021-02-06). "Oxford/AstraZeneca COVID shot less effective against South African variant: study". Reuters. สืบค้นเมื่อ 2021-02-08.
"British scientists warn over Indian coronavirus variant". Reuters. 2021-05-07. สืบค้นเมื่อ 2021-05-07.

rivm.nl

"Varianten van het coronavirus SARS-CoV-2" [Variants of the coronavirus SARS-CoV-2] (ภาษาดัตช์). Rijksinstituut voor Volksgezondheid en Milieu, RIVM. 2021-02-16. สืบค้นเมื่อ 2021-02-16.

sacoronavirus.co.za

Mkhize, Z (2020-12-18). "Update on Covid-19 (18th December 2020)" (Press release). South Africa. COVID-19 South African Online Portal. สืบค้นเมื่อ 2020-12-23. Our clinicians have also warned us that things have changed and that younger, previously healthy people are now becoming very sick.

sciencemag.org

Kupferschmidt, K (2021-01-15). "New coronavirus variants could cause more reinfections, require updated vaccines". Science. American Association for the Advancement of Science. doi:10.1126/science.abg6028. สืบค้นเมื่อ 2021-02-02.
Wadman, M (2021-02-23). "California coronavirus strain may be more infectious - and lethal". Science News. doi:10.1126/science.abh2101. สืบค้นเมื่อ 2021-03-17.
Kupferschmidt, K (2020-12-20). "Mutant coronavirus in the United Kingdom sets off alarms but its importance remains unclear". Science Mag (ภาษาอังกฤษ). สืบค้นเมื่อ 2020-12-21.
Moutinho, Sofia (2021-05-04). "Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil".
Kupferschmidt, K (2020-12-23). "U.K. variant puts spotlight on immunocompromised patients' role in the COVID-19 pandemic". Science.

science.sciencemag.org

Faria, NR; Mellan, TA; Whittaker, C; Claro, IM; Candido, DS; Mishra, S; และคณะ (2021-05-21). "Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil". Science. 372 (6544): 815–821. doi:10.1126/science.abh2644. ISSN 0036-8075. PMID 33853970. Within this plausible region of parameter space, P.1 can be between 1.7 and 2.4 times more transmissible (50% BCI, 2.0 median, with a 99% posterior probability of being >1) than local non-P1 lineages and can evade 21 to 46% (50% BCI, 32% median, with a 95% posterior probability of being able to evade at least 10%) of protective immunity elicited by previous infection with non-P.1 lineages, corresponding to 54 to 79% (50% BCI, 68% median) cross-immunity ... We estimate that infections are 1.2 to 1.9 times more likely (50% BCI, median 1.5, 90% posterior probability of being >1) to result in mortality in the period after the emergence of P.1, compared with before, although posterior estimates of this relative risk are also correlated with inferred cross-immunity. More broadly, the recent epidemic in Manaus has strained the city’s health care system, leading to inadequate access to medical care. We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus health care system, or both. Detailed clinical investigations of P.1 infections are needed.

blogs.sciencemag.org

Lowe, D (2020-12-22). "The New Mutations". In the Pipeline. American Association for the Advancement of Science. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-01-29. สืบค้นเมื่อ 2020-12-23. I should note here that there's another strain in South Africa that is bringing on similar concerns. This one has eight mutations in the Spike protein, with three of them (K417N, E484K and N501Y) that may have some functional role.

sciencemediacentre.org

"expert reaction to VUI-21APR-02/B.1.617.2 being classified by PHE as a variant of concern". Science Media Centre. 2021-05-07. สืบค้นเมื่อ 2021-05-15.
"expert reaction to VUI-21APR-02/B.1.617.2 being classified by PHE as a variant of concern". Science Media Centre. 2021-05-07. สืบค้นเมื่อ 2021-05-15.

sciencespeaksblog.org

"COVID "Mega-variant" and eight criteria for a template to assess all variants". Science Speaks: Global ID News (ภาษาอังกฤษแบบอเมริกัน). 2021-02-02. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-21. สืบค้นเมื่อ 2021-02-20.

scientificamerican.com

Sutherland, S (2021-02-23). "COVID Variants May Arise in People with Compromised Immune Systems". Scientific American.

scribd.com

"The 2nd Covid-19 wave in South Africa:Transmissibility & a 501.V2 variant, 11th slide". www.scribd.com. 2020-12-19.

semanticscholar.org

api.semanticscholar.org

Shahhosseini, Nariman; Babuadze, George; Wong, Gary; Kobinger, Gary (2021). "Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern". Microorganisms. 9 (5): 926. doi:10.3390/microorganisms9050926. PMID 33925854. S2CID 233460887. สืบค้นเมื่อ 2021-05-04.
Nyberg, T; Twohig, KA; Harris, RJ; Seaman, SR; Flannagan, J; Allen, H; และคณะ (2021-06-15). "Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis". BMJ. 373: n1412. doi:10.1136/bmj.n1412. ISSN 1756-1833. PMID 34130987. S2CID 235187479.
Coutinho, RM; Marquitti, FM; Ferreira, LS; Borges, ME; da Silva, RL; Canton, O; และคณะ (2021-03-23). "Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant". medRxiv (Preprint): 9. doi:10.1101/2021.03.03.21252706. S2CID 232119656. สืบค้นเมื่อ 2021-04-29. The new variant was found to be about 2.6 times more transmissible (95% Confidence Interval (CI): 2.4-2.8) than previous circulating variant (s). ... Table 1: Summary of the fitted parameters and respective confidence intervals considering the entire period, November 1, 2020-January 31, 2021 maintaining the same pathogenicity of the previous variant. Parameter: Relative transmission rate for the new variant. Estimate: 2.61. 2.5%: 2.45. 97.5%: 2.76.
Ito, K; Piantham, C; Nishiura, H (2021-06-15). "Predicted domination of variant Delta of SARS-CoV-2 before Tokyo Olympic games, Japan". medRxiv (Preprint). doi:10.1101/2021.06.12.21258835. S2CID 235437370.
Rambaut, A; Holmes, EC; Á, O'Toole; Hill, V; McCrone, JT; Ruis, C; และคณะ (November 2020). "A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology". Nature Microbiology. 5 (11): 1403–1407. doi:10.1038/s41564-020-0770-5. PMC 7610519. PMID 32669681. S2CID 220544096. Cited in Alm et al.
Zhang, W; Davis, B; Chen, SS; Martinez, JS; Plummer, JT; Vail, E (2021). "Emergence of a novel SARS-CoV-2 strain in Southern California, USA". MedRxiv. doi:10.1101/2021.01.18.21249786. S2CID 231646931.
Voloch, CM; da Silva Francisco, R; de Almeida, LG; Cardoso, CC; Brustolini, OJ; Gerber, AL; และคณะ (2020). "Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil". doi:10.1101/2020.12.23.20248598. S2CID 229379623 – โดยทาง MedRxiv. {{cite journal}}: Cite journal ต้องการ |journal= (help)
Schroers, B; Gudimella, R; Bukur, T; Roesler, T; Loewer, M; Sahin, U (2021-02-04). "Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates". bioRxiv (ภาษาอังกฤษ). doi:10.1101/2021.02.04.429765. S2CID 231885609.
Wise, J (February 2021). "Covid-19: The E484K mutation and the risks it poses". BMJ. 372: n359. doi:10.1136/bmj.n359. PMID 33547053. S2CID 231821685.
Tu, H; Avenarius, MR; Kubatko, L; Hunt, M; Pan, X; Ru, P; และคณะ (2021-01-26). "Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio". bioRxiv (ภาษาอังกฤษ): 2021.01.12.426407. doi:10.1101/2021.01.12.426407. S2CID 231666860.
Mahase, E (March 2021). "Covid-19: Where are we on vaccines and variants?". BMJ. 372: n597. doi:10.1136/bmj.n597. PMID 33653708. S2CID 232093175.
Mahase, E (February 2021). "Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant". BMJ. 372: n296. doi:10.1136/bmj.n296. PMID 33526412. S2CID 231730012.

ssi.dk

files.ssi.dk

"Status for udvikling af SARS-CoV-2 Variants of Concern (VOC) i Danmark" [Status of development of SARS-CoV-2 Variants of Concern (VOC) in Denmark] (ภาษาเดนมาร์ก). Statens Serum Institut. 2021-02-27. สืบค้นเมื่อ 2021-02-27.
Lassaunière, R; Fonager, J; Rasmussen, M; Frische, A; Strandh, C; Rasmussen, T; และคณะ (2020-11-10). SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data (Preprint). Statens Serum Institut. เก็บจากแหล่งเดิมเมื่อ 2020-11-10. สืบค้นเมื่อ 2020-11-11.

covid19.ssi.dk

"Delta-PCR-testen" [The Delta PCR Test] (ภาษาเดนมาร์ก). Statens Serum Institut. 2021-02-25. สืบค้นเมื่อ 2021-02-27.

ssrn.com

papers.ssrn.com

Emary, KR; Golubchik, T; Aley, PK; Ariani, CV; Angus, BJ; Bibi, S; และคณะ (2021). "Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)". SSRN 3779160.

statnews.com

"Don't call it the 'British variant.' Use the correct name: B.1.1.7". STAT (ภาษาอังกฤษแบบอเมริกัน). 2021-02-09. สืบค้นเมื่อ 2021-02-12.
"The name game for coronavirus variants just got a little easier". stat. 2021-05-31.

straitstimes.com

"Malaysia identifies new Covid-19 strain, similar to one found in 3 other countries". The Straits Times (ภาษาอังกฤษ). 2020-12-23. สืบค้นเมื่อ 2021-01-10. Tan Sri Dr Noor Hisham Abdullah, said it is still unknown whether the strain - dubbed the "A701B" mutation - is more infectious than usual

telegraph.co.uk

Nuki, Paul; Newey, Sarah (2021-04-16). "Arrival of India's 'double mutation' adds to variant woes, but threat posed remains unclear". The Telegraph (ภาษาอังกฤษแบบบริติช). ISSN 0307-1235. สืบค้นเมื่อ 2021-04-17.
Donnelly, L (2021-01-26). "UK to help sequence mutations of Covid around world to find dangerous new variants". www.telegraph.co.uk. สืบค้นเมื่อ 2021-01-28.

theconversation.com

Cutler, Sally (2021-06-18). "'Nepal variant': what we've learned so far". The Conversation. สืบค้นเมื่อ 2021-06-18.

theguardian.com

"Danish Covid mink variant 'very likely extinct', but controversial cull continues". theguardian. 2020-11-19.

thehindu.com

Koshy, J (2021-04-08). "Coronavirus | Indian 'double mutant' strain named B.1.617". The Hindu (ภาษาIndian English).
"New coronavirus variant found in West Bengal". thehindu.
Bhattacharjee, Sumit (2021-05-03). "COVID-19 | A.P. strain at least 15 times more virulent". The Hindu (ภาษาIndian English).
Koshy, J (2021-04-08). "Coronavirus | Indian 'double mutant' strain named B.1.617". The Hindu (ภาษาIndian English).

thelancet.com

Sheikh, A; McMenamin, J; Taylor, B; Robertson, C (2021-06-14). "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness". The Lancet. doi:10.1016/S0140-6736(21)01358-1. ISSN 0140-6736. PMID 34139198.
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study, Dan Frampton, et al., The Lancet, Online, April 12, 2021

thestar.com.my

"Covid-19: Sarawak detects variant reported in the Philippines" (ภาษาอังกฤษ). 2021-04-30. สืบค้นเมื่อ 2021-04-30.

timesofindia.com

m.timesofindia.com

"Hyderabad: Mutant N440K 10 times more infectious than parent strain".

torontosun.com

"India's variant-fuelled second wave coincided with spike in infected flights landing in Canada". Toronto Sun. 2021-04-10. สืบค้นเมื่อ 2021-04-10.
"India's variant-fuelled second wave coincided with spike in infected flights landing in Canada". Toronto Sun. 2021-04-10. สืบค้นเมื่อ 2021-04-10.

uni-graz.at

"University of Graz". www.uni-graz.at. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-05-06. สืบค้นเมื่อ 2021-02-22.

uol.com.br

noticias.uol.com.br

Simões, E; Gaier, R (2021-03-08). "CoronaVac e Oxford são eficazes contra variante de Manaus, dizem laboratórios" [CoronaVac and Oxford are effective against Manaus variant, say laboratories]. UOL Notícias (ภาษาโปรตุเกส). Reuters Brazil. สืบค้นเมื่อ 2021-03-09.

virological.org

Rambaut, A; Loman, N; Pybus, O; Barclay, W; Barrett, J; Carabelli, A; และคณะ (2020-12-18). "Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations". Virological. สืบค้นเมื่อ 2021-06-14.
Rambaut, A; Loman, N; Pybus, O; Barclay, W; Barrett, J; Carabelli, A; และคณะ (2020). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations (Report). Written on behalf of COVID-19 Genomics Consortium UK. สืบค้นเมื่อ 2020-12-20.
Faria, NR; Claro, IM; Candido, D; LA, Moyses Franco; Andrade, PS; Coletti, TM; และคณะ (2021-01-12). "Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings". CADDE Genomic Network. virological.org. สืบค้นเมื่อ 2021-01-23.
"Detection of SARS-CoV-2 P681H Spike Protein Variant in Nigeria". Virological (ภาษาอังกฤษแบบอเมริกัน). 2020-12-23. สืบค้นเมื่อ 2021-01-01.

washingtonpost.com

Wroughton, L; Bearak, M (2020-12-18). "South Africa coronavirus: Second wave fueled by new strain, teen 'rage festivals'". The Washington Post. สืบค้นเมื่อ 2020-12-20.
Achenbach, J; Booth, W (2021-02-02). "Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples". The Washington Post. สืบค้นเมื่อ 2021-02-02.
Booth, W; Johnson, CY (2021-02-07). "South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant". The Washington Post. London. สืบค้นเมื่อ 2021-02-08. South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided 'minimal protection' against mild to moderate coronavirus infections caused by the new variant first detected in that country.

web.archive.org

"Tracking SARS-CoV-2 variants". who.int (ภาษาอังกฤษ). World Health Organization. เก็บจากแหล่งเดิมเมื่อ 2021-06-18.
"Living Evidence - SARS-CoV-2 variants". Agency for Clinical Innovation. nsw.gov.au. Ministry of Health (New South Wales). 2021-06-22. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-16. สืบค้นเมื่อ 2021-06-09.
"Nextclade" (What are the clades?). clades.nextstrain.org. เก็บจากแหล่งเดิมเมื่อ 2021-01-19. สืบค้นเมื่อ 2021-01-19.
"COVID "Mega-variant" and eight criteria for a template to assess all variants". Science Speaks: Global ID News (ภาษาอังกฤษแบบอเมริกัน). 2021-02-02. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-21. สืบค้นเมื่อ 2021-02-20.
Lowe, D (2020-12-22). "The New Mutations". In the Pipeline. American Association for the Advancement of Science. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-01-29. สืบค้นเมื่อ 2020-12-23. I should note here that there's another strain in South Africa that is bringing on similar concerns. This one has eight mutations in the Spike protein, with three of them (K417N, E484K and N501Y) that may have some functional role.
"PANGO lineages". cov-lineages.org. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-06-03. สืบค้นเมื่อ 2021-04-18.
"B.1.429". Rambaut Group, University of Edinburgh. PANGO Lineages. 2021-02-15. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-28. สืบค้นเมื่อ 2021-02-16.
"PANGO lineages Lineage P.2". COV lineages. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-04-28. สืบค้นเมื่อ 2021-01-28. P.2… Alias of B.1.1.28.2, Brazilian lineage
Santos, E (2021-03-13). "DOH reports COVID-19 variant 'unique' to PH, first case of Brazil variant". CNN Philippines. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-03-16. สืบค้นเมื่อ 2021-03-17.
"PH discovered new COVID-19 variant earlier than Japan, expert clarifies". CNN Philippines. 2021-03-13. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-03-17. สืบค้นเมื่อ 2021-03-17.
"Japan detects new coronavirus variant from traveler coming from PH". CNN Philippines. 2021-03-13. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-03-17. สืบค้นเมื่อ 2021-03-21.
"Lineage B.1.1.207". cov-lineages.org. Pango team. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-01-27. สืบค้นเมื่อ 2021-03-11.
"PANGO lineages Lineage B.1.618". cov-lineages. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-05-14. สืบค้นเมื่อ 2021-04-23.
Lassaunière, R; Fonager, J; Rasmussen, M; Frische, A; Strandh, C; Rasmussen, T; และคณะ (2020-11-10). SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data (Preprint). Statens Serum Institut. เก็บจากแหล่งเดิมเมื่อ 2020-11-10. สืบค้นเมื่อ 2020-11-11.
"University of Graz". www.uni-graz.at. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-05-06. สืบค้นเมื่อ 2021-02-22.
COG-UK update on SARS-CoV-2 Spike mutations of special interest: Report 1 (PDF) (Report). COVID-19 Genomics UK Consortium (COG-UK). 2020-12-20. p. 7. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2020-12-25. สืบค้นเมื่อ 2020-12-31.
"New, more infectious strain of COVID-19 now dominates global cases of virus: study". medicalxpress.com (ภาษาอังกฤษ). เก็บจากแหล่งเดิมเมื่อ 2020-11-17. สืบค้นเมื่อ 2020-08-16.
"PANGO lineages". cov-lineages.org. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-06-03. สืบค้นเมื่อ 2021-04-18.

who.int

"Tracking SARS-CoV-2 variants". who.int (ภาษาอังกฤษ). World Health Organization. เก็บจากแหล่งเดิมเมื่อ 2021-06-18.
"Coronavirus Disease (COVID-19) Situation Reports". who.int. World Health Organization.
Weekly epidemiological update on COVID-19 - 15 June 2021 (Situation report). World Health Organization. 2021-06-15. สืบค้นเมื่อ 2021-06-16.
Weekly epidemiological update on COVID-19 - 8 June 2021 (Situation report). World Health Organization. 2021-06-08. สืบค้นเมื่อ 2021-06-14.
"3.6 Considerations for virus naming and nomenclature". SARS-CoV-2 genomic sequencing for public health goals: Interim guidance, 8 January 2021. World Health Organization. 2021-01-08. p. 6. สืบค้นเมื่อ 2021-02-02.
-emergency-committee-regarding-the-coronavirus-disease-(covid-19) -pandemic "Statement on the sixth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic". World Health Organization. 2021-01-15. สืบค้นเมื่อ 2021-01-18. {{cite web}}: ตรวจสอบค่า |url= (help)
"Statement of the WHO Working Group on COVID-19 Animal Models (WHO-COM) about the UK and South African SARS-CoV-2 new variants" (PDF). World Health Organization. 2020-12-22. สืบค้นเมื่อ 2020-12-23.
"Weekly epidemiological update on COVID-19 - 11 May 2021". World Health Organization. 2021-05-11. สืบค้นเมื่อ 2021-05-12.
"Tracking SARS-CoV-2 variants". www.who.int (ภาษาอังกฤษ). 2021-05-31. สืบค้นเมื่อ 2021-06-05.
Weekly epidemiological update on COVID-19 - 27 April 2021 (Situation report). World Health Organization. 2021-04-27. สืบค้นเมื่อ 2021-06-14.
"Tracking SARS-CoV-2 variants". World Health Organization (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-06-17.{{cite web}}: CS1 maint: url-status (ลิงก์)
"SARS-CoV-2 mink-associated variant strain - Denmark". WHO Disease Outbreak News. 2020-11-06. สืบค้นเมื่อ 2021-03-19.
Weekly epidemiological update on COVID-19 - 8 June 2021 (Situation report). World Health Organization. 2021-06-08. Table 3. สืบค้นเมื่อ 2021-06-14.
Weekly epidemiological update on COVID-19 - 15 June 2021 (Situation report). World Health Organization. 2021-06-15. สืบค้นเมื่อ 2021-06-16.
Weekly epidemiological update on COVID-19 - 8 June 2021 (Situation report). World Health Organization. 2021-06-08. สืบค้นเมื่อ 2021-06-14.
"Weekly epidemiological update on COVID-19 - 11 May 2021". World Health Organization. 2021-05-11. สืบค้นเมื่อ 2021-05-12.

worldcat.org

Nyberg, T; Twohig, KA; Harris, RJ; Seaman, SR; Flannagan, J; Allen, H; และคณะ (2021-06-15). "Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis". BMJ. 373: n1412. doi:10.1136/bmj.n1412. ISSN 1756-1833. PMID 34130987. S2CID 235187479.
Zhao, S; Lou, J; Cao, L; Zheng, H; Chong, MK; Chen, Z; และคณะ (2021-01-28). "Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis". Journal of Travel Medicine. 28 (2). doi:10.1093/jtm/taab011. ISSN 1195-1982. PMC 7928809. PMID 33506254.
Faria, NR; Mellan, TA; Whittaker, C; Claro, IM; Candido, DS; Mishra, S; และคณะ (2021-05-21). "Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil". Science. 372 (6544): 815–821. doi:10.1126/science.abh2644. ISSN 0036-8075. PMID 33853970. Within this plausible region of parameter space, P.1 can be between 1.7 and 2.4 times more transmissible (50% BCI, 2.0 median, with a 99% posterior probability of being >1) than local non-P1 lineages and can evade 21 to 46% (50% BCI, 32% median, with a 95% posterior probability of being able to evade at least 10%) of protective immunity elicited by previous infection with non-P.1 lineages, corresponding to 54 to 79% (50% BCI, 68% median) cross-immunity ... We estimate that infections are 1.2 to 1.9 times more likely (50% BCI, median 1.5, 90% posterior probability of being >1) to result in mortality in the period after the emergence of P.1, compared with before, although posterior estimates of this relative risk are also correlated with inferred cross-immunity. More broadly, the recent epidemic in Manaus has strained the city’s health care system, leading to inadequate access to medical care. We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus health care system, or both. Detailed clinical investigations of P.1 infections are needed.
Sheikh, A; McMenamin, J; Taylor, B; Robertson, C (2021-06-14). "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness". The Lancet. doi:10.1016/S0140-6736(21)01358-1. ISSN 0140-6736. PMID 34139198.
Nuki, Paul; Newey, Sarah (2021-04-16). "Arrival of India's 'double mutation' adds to variant woes, but threat posed remains unclear". The Telegraph (ภาษาอังกฤษแบบบริติช). ISSN 0307-1235. สืบค้นเมื่อ 2021-04-17.
Wu, Fan; Zhao, Su; Yu, Bin; Chen, Yan-Mei; Wang, Wen; Song, Zhi-Gang; Hu, Yi; Tao, Zhao-Wu; Tian, Jun-Hua; Pei, Yuan-Yuan; Yuan, Ming-Li; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen (2020). "A new coronavirus associated with human respiratory disease in China". Nature. 579 (7798): 265–269. doi:10.1038/s41586-020-2008-3. ISSN 0028-0836.
Zhou, Peng; Yang, Xing-Lou; Wang, Xian-Guang; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Huang, Chao-Lin; Chen, Hui-Dong; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Liu, Lin-Lin; Yan, Bing; Zhan, Fa-Xian; Wang, Yan-Yi; Xiao, Geng-Fu; Shi, Zheng-Li (2020). "A pneumonia outbreak associated with a new coronavirus of probable bat origin". Nature. 579 (7798): 270–273. doi:10.1038/s41586-020-2012-7. ISSN 0028-0836.
Okada, Pilailuk; Buathong, Rome; Phuygun, Siripaporn; Thanadachakul, Thanutsapa; Parnmen, Sittiporn; Wongboot, Warawan; Waicharoen, Sunthareeya; Wacharapluesadee, Supaporn; Uttayamakul, Sumonmal; Vachiraphan, Apichart; Chittaganpitch, Malinee; Mekha, Nanthawan; Janejai, Noppavan; Iamsirithaworn, Sopon; Lee, Raphael TC; Maurer-Stroh, Sebastian (2020). "Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020". Eurosurveillance. 25 (8). doi:10.2807/1560-7917.ES.2020.25.8.2000097. ISSN 1560-7917.
Mandavilli, A; Mueller, B (2021-03-02). "Why Virus Variants Have Such Weird Names". The New York Times. ISSN 0362-4331. สืบค้นเมื่อ 2021-03-02.

youtube.com

"COG-UK Showcase Event". สืบค้นเมื่อ 2020-12-25 – โดยทาง YouTube.